Apoptosis signaling by death receptors

European Journal of Biochemistry

Volumn 254, Issue 3, 1998, Pages 439-459

  Schulze Osthoff, Klaus ^a   Ferrari, Davide ^a   Los, Marek ^a   Wesselborg, Sebastian ^a   Peter, Marcus E ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Bcl 2; Caspase; CD95 (APO 1 Fas); Death receptor; Inhibitor of apoptosis protein; Nuclear factor B; Tumor necrosis factor; Tumor necrosis factor related apoptosis inducing ligand; Tumor necrosis factor receptor related apoptosis mediating protein

Indexed keywords

FAS ANTIGEN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CYTOTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DENSITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032526268     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2540439.x     Document Type: Review

References (281)

1. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. & Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function, Nature 390, 175-179.
2. Bodmer, J. L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schroter, M., Becker, K., Wilson, A., French, L. E., Browning, J. L., MacDonald, H. R. & Tschopp, J. (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95), Immunity 6, 79-88.
3. Nocentini, G., Giunchi, L., Ronchetti, S., Krausz, L. T., Bartoli, A., Moraca, R., Migliorati, G. & Riccardi, C. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis, Proc. Natl Acad. Sci. USA 94, 6216-6221.
4. Itoh, N., Yonehara, S. I. A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. & Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 66, 233-243.
5. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li Weber, M., Richards, S., Dhein, J., Trauth, B. C., Pansting, I. K. & Krammer, P. H. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen, J. Biol. Chem. 267, 10709-10715.
6. Tartaglia, L. A., Ayres, T. M., Wong, G. H. & Goeddel, D. V. (1993) A novel domain within the 55 kd TNF receptor signals cell death, Cell 74, 845-853.
7. Itoh, N. & Nagata, S. (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen, J. Biol. Chem. 268, 10932-10937.
8. Chinnaiyan, A. M. O'Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J. & Dixit, V. M. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95, Science 274, 990-992.
9. Kitson, J., Raven, T., Jiang, Y. P., Goeddel, D. V., Giles, K. M., Pun, K. T., Grinham, C. J., Brown, R. & Farrow, S. N. (1996) A death-domain-containing receptor that mediates apoptosis, Nature 384, 372-375.
10. Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D. & Ashkenazi, A. (1996) Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB, Curr. Biol. 6, 1669-1676.
11. Screaton, G. R., Xu, X. N., Olsen, A. L., Cowper, A. E., Tan, R., McMichael, A. J. & Bell, J. I. (1997) LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing, Proc. Natl Acad. Sci. USA 94, 4615-4619.
12. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J. & Dixit, V. M. (1997) The receptor for the cytotoxic ligand TRAIL, Science 276, 111-113.
13. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R. & Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL, Science 277, 815-818.
14. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Badwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P. & Ashkenazi, A. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors, Science 277, 818-821.
15. Walczak, H., Degli Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G. & Rauch, C. T. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL, EMBO J. 16, 5386-5397.
16. MacFarlane, M., Ahmadi, M., Srinivasula, S. M., Fernades Alnemri, T., Cohen, G. M. & Alnemri, E. S. (1997) Identification of two novel receptors for the cytotoxic ligand TRAIL, J. Biol. Chem. 272, 25417-25420.
17. Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J. & Hood, L. (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway, Immunity 7, 821-830.
18. Schneider, P., Thome, M., Burs, K., Bodmer, J. L., Hofman, K., Kataoka, T., Holler, N. & Tschopp, J. (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB, Immunity 7, 831-836.
19. Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C. P., DuBose, R. F., Goodwin, R. G. & Smith, C. A. (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family, J. Exp. Med. 186, 1165-1170.
20. Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A. & Goodwin, R. G. (1997) The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain, Immunity 7, 813-820.
21. Marsters, S. A., Sheridan, J. P., Pitti, R. M., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P. & Ashkenazi, A. (1997) A novel receptor for Apo2L/TRAIL contains a truncated death domain, Curr. Biol. 7, 1003-1006.
22. Mongkolsapaya, J., Cowper, A. E., Xu, X. N., Morris, G., McMichael, A. J., Bell, J. I. & Screaton, G. R. (1998) Lymphocyte inhibitor of TRAIL: a new receptor protecting lymphocytes from the death ligand TRAIL, J. Immunol. 160, 3-6.
23. Beutler, B. & van Huffel, C. (1994) Unraveling function in the TNF ligand and receptor families, Science 264, 667-668.
24. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C. & Smith, C. A. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis, Immunity 3, 673-682.
25. Eck, M. J., Ultsch, M., Rinderknecht, E., de Vos, A. M. & Sprang, S. R. (1992) The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9-Å resolution, J. Biol. Chem. 267, 2119-2122.
26. Jones, E. Y., Stuart, D. I. & Walker, N. P. (1992) Crystal structure of TNF, Immunol. Ser. 56, 93-127.
27. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H. & Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation, Cell 73, 431-445.
28. Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Moeller, P. & Krammer, P. H. (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on crosslinking of APO-1 cell surface antigens, J. Immunol. 149, 3166-3173.
29. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J. & Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells, Nature 385, 729-733.
30. Moss, M. L., Jin, S. L., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Warner, J., Willard, D. & Becherer, J. D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha, Nature 385, 733-736.
31. Vassalli, P. (1992) The pathopyhsiology of tumor necrosis factors, Annu. Rev. Immunol. 10, 411-452.
32. Tracey, K. J. & Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease, Annu. Rev. Cell Biol. 9, 317-343.
33. Bazzoni, F. & Beutler, B. (1996) The tumor necrosis factor ligand and receptor families, New Engl. J. Med. 334, 1717-1725.
34. Fiers, W., Beyaert, R., Boone, F., Cornelis, S., Declercq, W., Decoster, E., Denecker, G., Depuydt, B., De Valck, D., De Wilde, G., Goossens, V., Grooten, J., Haegeman, G., Heyninck, K., Penning, L., Plaisance, S., Vancompernolle, K., Van Criekinge, W., Vandenabeele, P., Vanden Berghe, W., Van de Craen, M., Vandevoorde, V. & Vercammen, D. (1996) TNF induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis, J. Inflamm. 47, 67-75.
35. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moeller, P., Falk, W., Debatin, K. M. & Krammer, P. H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 245, 301-305.
36. Yonehara, S., Ishii, A. & Yonehara, M. (1989) A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor, J. Exp. Med. 169, 1747-1756.
37. Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Bäumler, C., Hellbardt, S., Germer, M. & Debatin, K. M. (1994) The role of APO-1-mediated apoptosis in the immune system, Immunol. Rev. 142, 175-191.
38. Schulze-Osthoff, K. (1994) The Fas/APO-1 receptor and its deadly ligand, Trends Cell Biol 4, 421-426.
39. Nagata, S. (1997) Apoptosis by death factor, Cell 88, 355-365.
40. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature 356, 314-317.
41. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. & Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell 76, 969-976.
42. Adachi, M., Watanabe Fukunaga, R. & Nagata, S. (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice, Proc. Natl Acad. Sci. USA 90, 1756-1760.
43. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. & Puck, J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferalive syndrome, Cell 81, 935-946.
44. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A., Debatin, K. M., Fischer, A. & de Villartay, J. P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science 268, 1347-1349.
45. Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L. & Elkon, K. B. (1996) The Canale-Smith syndrome: an inherited autoimmune disorder associated with defective lymphocyte apoptosis and mutations in the Fas gene, N. Engl. J. Med. 335, 1643-1649.
46. Dhein, J., Walczak, H., Baeumler, C., Debatin, K. M. & Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1/ (Fas/ CD95), Nature 373, 438-441.
47. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. & Green, D. R. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature 373, 441-444.
48. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el Khatib, M., Sherr, D. H., Stanger, B. Z. & Marshak Rothstein, A. (1995) Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature 373, 444-448.
49. 2+-independent T cell-mediated cytotoxicity, J. Exp. Med. 177, 195-200.
50. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H. & Okumura, K. (1994) Fas and its ligand in a general mechanism of T cell mediated cytotoxicity, Proc. Natl Acad. Sci. USA 91, 4930-4934.
51. Herron, L. R., Eisenberg, R. A., Roper, E., Kakkanaiah, V. N., Cohen, P. L. & Kotzin, B. L. (1993) Selection of the T cell receptor repertoire in Lpr mice, J. Immunol. 151, 3450-3459.
52. Singer, G. G. & Abbas, A. K. (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice, Immunity 1, 365-371.
53. Cornall, R. J., Goodnow, C. C. & Cyster, J. G. (1995) The regulation of self-reactive B cells, Curr. Opin. Immunol. 7, 804-811.
54. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K. M. & Krammer, P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
55. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. & Pardee, A. B. (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268, 429-431.
56. Katsikis, P. D., Wunderlich, E. S., Smith, C. A. & Herzenberg, L. A. (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals, J. Exp. Med. 181, 2029-2036.
57. Debatin, K. M., Fahrig-Faissner, A., Enenkel-Stoodt, S., Kreuz, W., Benner, A. & Krammer, P. H. (1994) High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children, Blood 83, 3101-3103.
58. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. & Ferguson, T. A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege, Science 270, 1189-1192.
59. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. & Duke, R. C. (1995) A role for CD95 ligand in preventing graft rejection, Nature 377, 630-632.
60. Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R. & Ferguson, T. A. (1996) CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance, Immunity 5, 7-16.
61. Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X. & Ferguson, T. A. (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J. Clin. Invest. 99, 396-402.
62. Lau, H. T., Yu, M., Fontana, A. & Streckert, C. J. J. (1996) Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice, Science 273, 109-112.
63. Selawry, H. P. & Cameron, D. F. (1993) Sertoli cell-enriched fractions in successful islet cell transplantation, Cell. Transplant. 2, 123-129.
64. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J. & Tschopp, J. (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape, Science 274, 1363-1366.
65. O'Connell, J., O'Sullivan, G. C., Collins, J. K. & Shanahan, F. (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand, J. Exp. Med. 184, 1075-1082.
66. Strand, S., Hofmann, W. J., Hug, H., Mueller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H. & Galle, P. R. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells, A mechanism of immune evasion? Nat. Med. 2, 1306-1307.
67. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R. & Kratzke, R. A. (1997) Human lung carcinomas express Fas ligand, Cancer Res. 57, 1007-1012.
68. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J. & Dietrich, P. Y. (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99, 1173-1178.
69. Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K. J. & Takahashi, H. (1997) Expression of Fas ligand in liver metastases of human coIonic adenocarcinomas, Proc. Natl Acad. Sci. USA 94, 6420-6425.
70. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drumond, A. H. & Nagata, S. (1996) Fas ligand in human serum, Nat. Med. 2, 317-322.
71. Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H. & Runkel, L. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage, J. Exp. Med. 182, 1223-1230.
72. Braun, M. Y., Lowin, B., French, L., Acha Orbea, H. & Tschopp, J. (1996) Cytotoxic T cells deficient in both functional fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease, J. Exp. Med. Med. 183, 657-661.
73. Chervonsky, A. V., Wang, Y., Wong, F. S., Flavell, R. A., Janeway, C. A. Jr & Matis, L. A. (1997) The role of Fas in autoimmune diabetes, Cell 89, 17-24.
74. Sabelko, K. A., Kelly, K. A., Nalm, M. H., Cross, A. H. & Russell, J. H. (1997) Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis but are not essential for immune privilege in the central nervous system, J. Immunol. 159, 3096-3099.
75. Waldner, H., Sobel, R. A., Howard, E. & Kuchroo, V. K. (1997) Fas and FasL deficient mice are resistant to induction of autoimmune encephalomyelitis, J. Immunol. 159, 3100-3103.
76. Allison, J., Georgiou, H. M., Strasser, A. & Vaux, D. L. (1997) Transgenic expression of CD95 ligand on islet β-cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts, Proc. Natl Acad. Sci. USA 94, 3943-3947.
77. Seino, K., Kayagaki, N., Okumura, K. & Yagita, H. (1997) Antitumor effect of locally produced CD95 ligand, Nat. Med. 3, 165-170.
78. Abreu-Martin, M. T., Vidrich, A., Lynch, D. H. & Targan, S. R. (1995) Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen, J. Immunol. 155, 4147-4154.
79. Alderson, M. R., Armitage, R. J., Maraskovsky, K., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. & Lynch, D. H. (1993) Fas transduces activation signals in normal human T lymphocytes, J. Exp. Med. 178, 2231-2235.
80. Mapara, M. Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H. & Dorken, B. (1993) APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression, Eur. J. Immunol. 23, 702-708.
81. Aggarwal, B. B., Singh, S., LaPushin, R. & Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor, FEBS Lett. 364, 5-8.
82. Freiberg, R. A., Spencer, D. M., Choate, K. A., Duh, H. J., Schreiber, S. L., Crabtree, G. R. & Khavari, P. A. (1997) Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts, J. Invest. Dermatol. 108, 215-219.
83. Schulze-Osthoff, K., Krammer, P. H. & Droege, W. (1994) Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death, EMBO J. 13, 4587-4596.
84. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R. & Galluzzo, A. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis, Science 275, 960-963.
85. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., Kruzel, F. & Radinsky, R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression, Mol. Cell Biol. 15, 3032-3040.
86. Huber, A. O., Zoering, M., Lyon, D., Suda, T., Nagata, S. & Evan, G. I. (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis, Science 278, 1305-1309.
87. Bissonnette, R. P., McGahon, A., Mahboubi, A. & Green, D. R. (1994) Functional Myc-Max heteodimer is required for activation-induced apoptosis in T cell hyhridomas, J. Exp. Med. 180, 2413-2418.
88. Friesen, C., Herr, I., Krammer, P. H. & Debatin, K. M. (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug induced apoptosis in leukemia cells, Nat. Med. 2, 574-577.
89. Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H. & Galle, P. R. (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53, J. Clin. Invest. 99, 403-413.
90. Fulda, S., Sieverts, H., Friesen, C., Herr, I. & Debatin, K. M. (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells, Cancer Res. 57, 3823-3829.
91. Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J. & Kaufmann, S. H. (1997) Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions, Blood 90, 935-943.
92. Gamen, S., Anel, A., Lasierra, P., Alava, M. A., Martinez, Lorenzo, M. J., Pineiro, A. & Naval, J. (1997) Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way, FEBS Lett. 417, 360-364.
93. Rehemtulla, A., Hamilton, C. A., Chinnaiyan, A. M. & Dixit, V. M. (1997) Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1), J. Biol. Chem. 272, 25783-25786.
94. Aragane, Y., Kulms, D., Metze, D., Wilkes, G., Poeppelmann, B., Luger, T. A. & Schwarz, T. (1998) Ultraviolet light induces apoptosis via activation of CD95 (Fas/APO-1) independently from its ligand CD95L, J. Cell Biol. 140, 171-182.
95. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. & Williamson, B. (1975) An endotoxin-induced factor that causes necrosis of tumors, Proc. Natl Acad. Sci. USA 72, 3666-3670.
96. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y., Mathison, J., Ulevitch, R. & Cerami, A. (1985) Identity of tumor necrosis factor and the macrophage-secreted factor cachectin, Nature 316, 552-554.
97. Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A. J. & Goeddel, D. V. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses, Proc. Natl Acad. Sci. USA 88, 9292-9296.
98. Tartaglia, L. A., Pennica, D. & Goeddel, D. V. (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor, J. Biol. Chem. 268, 18542-18548.
99. Wong, G. H., Tartaglia, L. A., Lee, M. S. & Goeddel, D. V. (1992) Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor, J. Imnumol. 149, 3350-3353.
100. Vandenabeele, P., Declercq, W., Vanhaesebroeck, B., Grooten, J. & Fiers, W. (1995) Both TNF receptors are required forTNF-mediated induction of apoptosis in PC60 cells, J. Immunol. 154, 2904-2913.
101. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. & Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor, Cell 83, 793-802.
102. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. (1996) Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response, J. Exp. Med. 184, 1397-1411.
103. Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S. & Old, L. (1997) Characterization of tumor necrosis factor-deficient mice, Proc. Natl Acad. Sci. USA 94, 8093-8098.
104. Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H. & Kollias, G. (1997) Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor, Proc. Natl Acad. Sci. USA 94, 6319-6323.
105. Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins, Cell 83, 1243-1252.
106. Garcia, I., Miyazaki, Y., Araki, K., Araki, M., Lucas, R., Grau, G. E., Milon, G., Belkaid, Y., Montixi, C., Lesslauer, W. & Vassalli, P. (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections, Eur. J. Immunol. 25, 2401 -2407.
107. Shimamoto, Y., Chen, R. L., Bollon, A., Chang, A. & Khan, A. (1988) Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock, Immunol. Lett. 17, 311-317.
108. Hayward, M. & Fiedler Nagy, C. (1987) Mechanisms of bone loss: rheumatoid arthritis, periodontal disease and osteoporosis, Agents Actions, 22, 251-254.
109. Marsters, S. A., Pitti, R. M., Donahue, C. J., Ruppert, S., Bauer, K. D. & Ashkenazi, A. (1996) Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA, Curr. Biol. 6, 750-752.
110. Katsikis, P. D., Garciaojeda, M. E., Torresroca, J. F., Tijoe, I. M., Smith, C. A., Herzenberg, L. A. & Herzenberg, L. A. (1997) Interleukin-1β converting enzyme like protease involvement in Fas induced and activation induced peripheral blood T cell apoptosis in HIV infection: TNF related apoptosis inducing ligand can mediate activation induced T cell death in HIV infection, J. Exp. Med. 186, 1365-1372.
111. Jeremias, I., Herr, I., Boehler, T. & Debatin, K.-M. (1998) TRAIL/ Apo-2 ligand-induced apoptosis in human T cells, Eur. J. Immunol. 28, 143-152.
112. Huang, B., Eberstadt, M., Olejniczak, E. T., Meadows, R. P. & Fesik, S. W. (1996) NMR structure and mutagenesis of the Fas (APO-1/ CD95) death domain, Nature 384, 638-641.
113. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell 81, 505-512.
114. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H. & Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain, J. Biol. Chem. 270, 7795-7798.
115. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. & Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death, Cell 81, 513-523.
116. Hsu, H., Xiong, J. & Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation, Cell 81, 495-504.
117. Park, A. & Baichwal, V. R. (1996) Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD, J. Biol. Chem. 271, 9858-9862.
118. Ting, A. T., Pimentel Muinos, F. X. & Seed, B. (1996) RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/ APO-1-initiated apoptosis, EMBO J. 15, 6189-6196.
119. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex, Immunity 4, 387-396.
120. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. & Peter, M. E. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, EMBO J. 14, 5579-5588.
121. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E. & Dixit, V. M. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex, Cell 85, 817-827.
122. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. & Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death, Cell 85, 803-815.
123. Srinivasula, S. M., Ahmad, M., Fernandes Alnemri, T., Litwack, G. & Alnemri, E. S. (1996) Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases, Proc. Natl Acad. Sci. USA 93, 14486-14491.
124. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W. & Yuan, J. (1996) Human ICE/ CED-3 protease nomenclature, Cell 87, 171.
125. Chinnaiyan, A. M., Tepper, C. G., Seidin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E. & Dixit, V. M. (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis, J. Biol. Chem. 271, 4961-4965.
126. Mariani, S. M., Matiba, B., Armandola, E. A. & Krammer, P. H. (1997) Interleukin 1 beta-converting enzyme related proteases/ caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells, J. Cell Biol. 137, 221-229.
127. Wajant, H., Johannes, F. J., Haas, E., Sieminski, K., Schwenzer, R., Schubert, G., Weiss, T., Grell, M. & Scheurich, P. (1998) Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but nto gene induction, Curr. Biol. 8, 113-116.
128. Duan, H. & Dixit, V. M. (1997) RAIDD is a new 'death' adaptor molecule, Nature 385, 86-89.
129. Ahmad, M., Srinivasula, S. M., Wang, L., Talanian, R. V., Litwack, G., Fernandes Alnemri, T. & Alnemri, E. S. (1997) CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/ tumor necrosis factor receptor-interacting protein RIP, Cancer Res. 57, 615-619.
130. Schievella, A. R., Chen, J. H., Graham, J. R. & Lin, L. L. (1997) MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase, J. Biol. Chem. 272, 12069-12075.
131. Yang, X., Khoravi Far, R., Chang, H. Y. & Baltimore, D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis, Cell 89, 1067-1076.
132. Cohen, G. M. (1997) Caspases: the executioners of apoptosis, Biochem. J. 326, 1-16.
133. Nicholson, D. N. & Thornberry, N. A. (1997) Caspases: killer proteases, Trends Biochem. Sci. 22, 299-306.
134. Enari, M., Hug, H. & Nagata, S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis, Nature 375, 78-81.
135. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W. & Schulze-Osthoff, K. (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis, Nature 375, 81-83.
136. Tewari, M. & Dixit, V. M. (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product, J. Biol. Chem. 270, 3255-3260.
137. Heinkelein, M., Pilz, S. & Jassoy, C. (1996) Inhibition of CD95 (Fas/ Apo1)-mediated apoptosis by vaccinia virus WR, Clin. Exp. Immunol. 103, 8-14.
138. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. & Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme, Cell 75, 641-652.
139. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H. & Peter, M. E. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC), EMBO J. 16, 2794-2804.
140. Muzio, M., Salvesen, G. S. & Dixit, V. M. (1997) FLICE induced apoptosis in a cell-tree system. Cleavage of caspase zymogens, J. Biol. Chem. 272, 2952-2956.
141. Orth, K., O'Rourke, K., Salvesen, G. S. & Dixit, V. M. (1996) Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases, J. Biol. Chem. 271, 20977-20980.
142. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz, L., Tomaselli, K. J., Wang, L., Yu, Z., Croce, C. M., Salveson, G., Earnshaw, W. C., Litwack, G. & Alnemri, E. S. (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32, Cancer Res. 55, 6045-6052.
143. Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G. & Alnemri, E. S. (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains, Proc. Natl Acad. Sci. USA 93, 7464-7469.
144. Hirata, H., Takahashi, A., Kobayashi, S., Yonehara, S., Sawai, H., Okazaki, T., Yamamoto, K. & Sasada, M. (1998) Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis, J. Exp. Med. 187, 587-600.
145. Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P. & Flavell, R. A. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice, Nature 384, 368-372.
146. Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. & Flavell, R. A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme, Science 267, 2000-2003.
147. Boudreau, N., Sympson, C., Werb, Z. & Bissell, M. (1995) Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix, Science 267, 891-893.
148. Tamura, T., Ishishara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S. & Taniguchi, T. (1995) An IRF-1 dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes, Nature 376, 596-599.
149. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Wardwell, S., Wie, F.-Y., Wong, K., Kamen, R. & Seshadri, T. (1995) Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock, Cell 80, 401-411.
150. Smith, D. J., McGuire, M. J., Tocci, M. J. & Thiele, D. L. (1997) IL-1β convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms, J. Immunol. 158, 163-170.
151. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. & Dixit, V. M. (1995) Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase, Cell 81, 801-809.
152. Wang, Z. Q., Stingl, L., Morrison, C., Jantsch, M., Los, M., Schulze-Osthoff, K. & Wagner, E. F. (1997) PARP is important for genomic stability but dispensable in apoptosis, Genes & Dev. 11, 2347-2358.
153. Rudel, T. & Bokoch, G. M. (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2, Science 276, 1571-1574.
154. Enari, M., Sakahiera, H., Yokoyama, H., Okawa, K., Iwamatsu, A. & Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature 391, 43-50.
155. Liu, X., Zou, H., Slaughter, C. & Wang, X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis, Cell 89, 175-184.
156. Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. (1997) Apaf1, a human protein, homologous to C. elegans Ced-4, participates in cytochrome c-dependent activation ot caspase-3, Cell 90, 405-413.
157. Chinnaiyan, A. M. O'Rourke, K., Lane, B. R. & Dixit, V. M. (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death, Science 275, 1122-1126.
158. Wu, D., Wallen, H. D. & Nunez, G. (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9, Science 275, 1126-1129.
159. Hofmann, K., Bucher, P. & Tschopp, J. (1997) The CARD domain: a new apoptotic signalling motif, Trends Biochem. Sci. 22, 155-156.
160. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S. & Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade, Cell 91, 479-489.
161. Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell 86, 147-157.
162. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O. & Kimchi, A. (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-α, EMBO J. 15, 3861-3870.
163. Ruggiero, V., Johnson, S. E. & Baglioni, C. (1987) Protection from tumor necrosis factor cytotoxicity by protease inhibitors, Cell. Immunol. 107, 317-325.
164. Suffys, P., Beyaert, R., Van Roy, F. & Fiers, W. (1988) Involvement of a serine protease in tumour necrosis factor-mediated cytotoxicity, Eur. J. Biochem. 178, 257-265.
165. Kumar, S. & Baglioni, C. (1991) Protection from tumor necrosis factor mediated cytolysis by overexpression of plasminogen activator inhibitor type 2, J. Biol. Chem. 266, 20960-20964.
166. Dickinson, J. L., Bates, E. J., Ferrante, A. & Antalis, T. M. (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor-α induced apoptosis, J. Biol. Chem. 270, 27894-27904.
167. Wright, S. C., Wei, A. S., Zhong, J., Zheng, H., Kinder, D. H. & Larrick, J. W. (1994) Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation, J. Exp. Med. 180, 2113-2123.
168. Wright, S. C., Schellenberger, U., Wang, H., Kinder, D. H., Talhouk, J. W. & Larrick, J. W. (1997) Activation of CPP32-like proteases is not sufficient to trigger apoptosis. Inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity, J. Exp. Med. 186, 1107-1117.
169. Vercammen, D., Vandenabeele, P., Beyaert, R., Declercq, W. & Fiers, W. (1997) Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells, Cytokine 9, 801-808.
170. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z. & Kolesnick, R. N. (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis, J. Exp. Med. 180, 525-535.
171. Bose, R., Verheij, M., Haimovitz Friedman, A., Scotto, K., Fuks, Z. & Kolesnick, R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals, Cell 82, 405-414.
172. Cifone, M. G., Roncaioli, P., De Maria, R., Cumarda, G., Santoni, A., Ruberti, G. & Testi, R. (1995) Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal, EMBO J. 14, 5859-5868.
173. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D. & Kroenke, M. (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling, Cell 78, 1005-1015.
174. Gulbins, H., Bissonnette, R., Mahbouhi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier Bitterlich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A. & Green, D. (1995) FAS induced apoptosis is mediated via a ceramide initiated RAS signaling pathway, Immunity 2, 341-351.
175. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J. & Kroenke, M. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase, Cell 86, 937-947.
176. Machleidt, T., Kramer, B., Adam, D., Neumann, B., Schuetze, S., Wiegmann, K. & Kroenke, M. (1997) Function of the p55 tumor necrosis factor receptor 'death domain' mediated by phosphatidylcholine-specific phsopholipase C, J. Exp. Med. 184, 725-733.
177. Santana, P., Pena, L. A., Haimovitz Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon Cardo, C., Schuchman, E. H., Fuks, Z. & Kolesnick, R. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis, Cell 86, 189-199.
178. De Maria, R., Lenti, L., Malisan, F., d'Agostino, F., Tomassini, B., Zeuner, A., Rippo, M. R. & Testi, R. (1997) Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis, Nature 277, 1652-1655.
179. Suzuki, A., Iwasaki, M., Kato, M. & Wagai, N. (1997) Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling, Exp. Cell Res. 233, 41-47.
180. Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita, H. & Miyasaka, N. (1996) Ceramide induces apoptosis via CPP32 activation, FEBS Lett. 395, 267-271.
181. Dbaibo, G. S., Perry, D. K., Gamard, C. J., Platt, R., Poirier, G. G., Obeid, L. M. & Hannun, Y. A. (1997) Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway, J. Exp. Med. 185, 481-490.
182. Sillence, D. J. & Allan, D. (1997) Evidence against an early signalling role for ceramide in Fas-mediated apoptosis, Biochem. J. 324, 29-32.
183. Watts, J. D., Gu, M., Polverino, A. J., Patterson, S. D. & Aebersold, R. (1997) Fas-induced apoptosis of T cells occurs independently of ceramide generation, Proc. Natl Acad. Sci. USA 94, 7292-7296.
184. Liu, Z. G., Hsu, H., Goeddel, D. V. & Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death, Cell 87, 565-576.
185. Natoli, G., Costanzo, A., Ianni, A., Templeton, D. J., Woodgett, J. R., Balsano, C. & Levrero, M. (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway, Science 275, 200-203.
186. Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P. & Fiers, W. (1996) The p3X/RK mitogen activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor, EMBO J. 15, 1914-1923.
187. Cahill, M. A., Peter, M. E., Kischkel, F. C., Chinnaiyan, A. M., Dixit, V. M., Krammer, P. H. & Nordheim, A. (1996) CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases, Oncogene 13, 2087-2096.
188. Juo, P., Kuo, C. J., Reynolds, S. E., Konz, R. F., Raingeaud, J., Davis, R. J., Biemann, H. P. & Blenis, J. (1997) Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases, Mol. Cell Biol. 17, 24-35.
189. Lenczowski, J. M., Dominguez, L., Eder, A. M., King, L. B., Zacharchuk, C. M. & Ashwell, J. D. (1997) Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis, Mol. Cell Biol. 17, 170-181.
190. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K. & Gotoh, Y. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science 275, 90-94.
191. Huang, S., Jiang, Y., Li, Z., Nishida, E., Mathias, P., Lin, S., Ulevitch, R. J., Nemerow, G. R. & Han, J. (1997) Apoptosis signaling pathway in T cells is composed of ICE/Ced 3 family proteases and MAP kinase kinase 6b, Immunity 6, 739-749.
192. Nishina, H., Fischer, K. D., Radvanyi, L., Shahinian, A., Hakem, R., Rubie, E. A., Bernstein, A., Mak, T. W., Woodgett, J. R. & Penninger, J. M. (1997) Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3, Nature 385, 350-353.
193. Beyaert, R. & Fiers, W. (1994) Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not, FEBS Lett. 340, 9-16.
194. Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P. & Fiers, W. (1997) Cell death induction by receptors of the TNF family: towards a molecular understanding, FEBS Lett 410, 96-106.
195. Kroemer, G. (1997) Mitochondrial control of apoptosis, Immunol. Today 18, 44-51.
196. Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M. & Kroemer, G. (1997) The apoptosisnecrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death, Oncogene 15, 1573-1581.
197. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis, J. Exp. Med. 285, 1481-1486.
198. Laster, S. M., Wood, J. G. & Gooding, L. R. (1988) Tumor necrosis factor can both induce apoptotic and necrotic forms of cell lysis, J. Immunol. 141, 2629-2635.
199. Matthews, N. & Neale, M. L. (1987) Studies on the mode of action of tumor necrosis factor on tumor cells in vitro, Lymphokines 14, 223-252.
200. Schulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A. & Fiers, W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation, J. Biol. Chem. 267, 5317-5323.
201. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G. & Fiers, W. (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF, EMBO J. 12, 3095-3104.
202. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C. & Raff, M. C. (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA, Nature 361, 365-369.
203. Hug, H., Enari, M. & Nagata, S. (1994) No requirement of reactive oxygen intermediates in Fas-mediated apoptosis, FEBS Lett. 351, 311-313.
204. Schulze-Osthoff, K., Los, M. & Baeuerle, P. A. (1995) Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes, Biochem. Pharmacol. 50, 735-741.
205. Wong, G. H. & Goeddel, D. V. (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways, J. Immunol. 152, 1751-1755.
206. Grell, M., Krammer, P. H. & Scheurich, P. (1994) Segregation of APO-1/Fas antigen and tumor necrosis factor-mediated apoptosis, Eur. J. Immunol. 24, 2563-2566.
207. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J. & Mountz, J. D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science 263, 1759-1762.
208. Mysler, E., Bini, P., Drappa, J., Ramos, P., Friedman, S. M., Krammer, P. H. & Elkon, K. B. (1994) The apoptosis-1/Fas protein in human systemic lupus erythematosus, J. Clin. Invest. 93, 1029-1034.
209. Knipping, E., Krammer, P. H., Lehman, T. J., Mysler, E. & Elkon, K. B. (1995) Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis, Arthritis Rheum. 38, 1735-1737.
210. Sato, T., Irie, S., Kitada, S. & Reed, J. C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas, Science 268, 411-415.
211. Yanagisawa, J., Takahashi, M., Kanki, H., Yano Yanagisawa, H., Tazunoki, T., Sawa, E., Nishitoba, T., Kamishohara, M., Kobayashi, E., Kataoka, S. & Sato, T. (1997) The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis, J. Biol. Chem. 272, 8539-8545.
212. Cuppen, E., Nagata, S., Wieringa, B. & Hendriks, W. (1997) No evidence for involvement of mouse proteine tyrosine phosphatase-Bas-like Fas-associated phosphatase-1 in Fas-mediated apoptosis, J. Biol. Chem. 272, 30215-30220.
213. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M. & Yeh, E. T. (1996) Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin, J. Immunol. 157, 4277-4281.
214. Gong, L., Kamitani, T., Fujise, K., Caskey, L. S. & Yeh, E. T. H. (1997) Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, ubc9, J. Biol. Chem. 272, 28 198-28201.
215. Becker, K., Schneider, P., Hofmann, K., Mattmann, C. & Tschopp, J. (1997) Interaction of Fas (APO-1/CD95) with proteins implicated in the ubiquitination pathway, FEBS Lett. 412, 102-106.
216. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J. L., Schroter, M., Scaffidi, C., Krammer, P. H., Peter, M. E. &. Tschopp, J. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature 386, 517-521.
217. Hu, S., Vincenz, C., Buller, M. & Dixit, V. M. (1997) A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1-induced apoptosis, J. Biol. Chem. 272, 9621-9624.
218. Bertin, J., Armstrong, R. C., Ottilie, S., Martin, D. A., Wang, Y., Banks, S., Wang, G. H., Senkevich, T. G., Alnemri, E. S., Moss, B., Lenardo, M. J., Tomaselli, K. J. & Cohen, J. I. (1997) Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis, Proc. Natl Acad. Sci. USA 94, 1172-1176.
219. Peter, M. E., Medema, J. P. & Krammer, P. H. (1997) Does the Caenorhabditis elegans protein CED-4 contain a region of homology to the mammalian death effector domain? Cell Death Diff. 4, 523-525.
220. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodme, J. L., Schroeter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E. & Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP, Nature 388, 190-195.
221. Shu, H. B., Halpin, D. R. & Goeddel, D. V. (1997) Casper is a FADD- and caspase-related inducer of apoptosis, Immunity 6, 751-763.
222. Hu, S., Vincenz, C., Ni, J., Gentz, R. & Dixit, V. M. (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis, J. Biol. Chem. 272, 17255-17257.
223. Srinivasula, S. M., Ahmad, M., Ottilie, S., Bullrich, F., Banks, S., Wang, Y., Fernandes Alnemri, T., Croce, C. M., Litwack, G., Tomaselli, K. J., Armstrong, R. C. & Alnemri, E. S. (1997) FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis, J. Biol. Chem. 272, 18542-18545.
224. Goltsev, Y. V., Kovalenko, A. V., Arnold, E., Varfolomeev, E. E., Brodianskii, V. M. & Wallach, D. (1997) CASH, a novel caspase homologue with death effector domains, J. Biol. Chem. 272, 19641-19644.
225. Inohara, N., Koseki, T., Hu, Y., Chen, S. & Nunez, G. (1997) CLARP, a death-effector domain-containing protein-interacts with caspase-8 and regulates apoptosis, Proc. Natl Acad. Sci. USA 94, 1017-10722.
226. Han, D. K. M., Chaudry, P. M., Wright, M. E., Friedman, C., Trask, B. J., Riedel, R. T., Baskin, D. G., Schwarz, S. M. & Hood, L. (1997) MRIT, a novel death-effector domain-containing protein interacts with capsases and BclXL and initiates cell death, Proc. Natl Acad. Sci. USA 94, 11333-11338.
227. Peter, M. E., Kischkel, F. C., Scheuerpflug, C., Medema, J. P., Debatin, K. M. & Krammer, P. H. (1997) Resistance of cultured peripheral T cells towards activation induced cell death involves a lack of recuitment of FLICE to the death-inducing signaling complex (DISC), Eur. J. Immunol. 27, 1207-1212.
228. Roy, N., Mahadevan, R. S., McLean, M., Shutler, G. & Yaraghi, Z. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy, Cell 80, 167-178.
229. Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van Dongen, J. L., Gilfillan, M. C., Shiels, H., Hardwick, J. M. & Thompson, C. B. (1996) A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors, EMBO J. 15, 2685-2694.
230. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton Horvat, G., Farahani, R., McLean, M., Ikeda, J. E., MacKenzie, A. & Korneluk, R. G. (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes, Nature 379, 349-353.
231. Ambrosini, G., Adida, C. & Altieri, D. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med. 3, 917-921.
232. Shu, H. B., Takeuchi, M. & Goeddel, D. V. (1996) The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor 1 signaling complex, Proc. Natl Acad. Sci. USA 93, 13973-13978.
233. Deveraux, Q., Takahashi, R., Salvesen, G. S. & Reed, J. C. (1997) X-linked IAP is a direct inhibitor of cell death proteases, Nature 388, 300-303.
234. Roy, N., Deveraux, Q. L., Takahashi, R., Salvesen, G. S. & Reed, J. C. (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases, EMbO J. 16, 6914-6925.
235. Bertin, J., Mendrysa, S. M., LaCount, D. J., Gaur, S., Krebs, J. F., Armstrong, R. C., Tomaselli, K. J. & Friesen, P. D. (1996) Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease, J. Virol. 70, 6251-6259.
236. Xue, D. & Horvitz, H. R. (1995) Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein, Nature 377, 248-251.
237. Komiyama, T., Ray, C. A., Pickup, D. J., Howard, A. D., Thornberry, N. A., Peterson, E. P. & Salvesen, G. (1994) Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA, J. Biol. Chem. 269, 19331-19337.
238. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. & Ballard, D. W. (1997) Suppression of tumor necrosis fator-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control, Proc. Natl. Acad. Sci. USA 94, 10657-10621.
239. Reed, J. C. (1997) Double identity for proteins of the Bcl-2 family, Nature 387, 773-776.
240. Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis, Nat. Med. 3, 614-620.
241. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74, 609-619.
242. Boise, L. H., Gonzalez Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G. & Thompson, C. B. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell 74, 597-608.
243. Cheng, E. H., Levine, B., Boise, L. H., Thompson, C. B. & Hardwick, J. M. (1996) Bax-independent inhibition of apoptosis by Bcl-XL, Nature 379, 554-556.
244. Clair, E. G. S., Anderson, S. J. & Oltvai, Z. N. (1997) Bcl-2 counters apoptosis by Bax heterodimerization dependent and independent mechanisms in the T cell lineage, J. Biol. Chem. 272, 29347-29355.
245. Simonian, P. L., Grillot, D. A., Andrews, D. W., Leber, B. & Nunez, G. (1996) Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death, J. Biol. Chem. 271, 32073-32077.
246. Simonian, P. L., Grillot, D. A. M. & Nunez, G. (1997) Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-X, and Bcl-2, Oncogene 15, 1871-1875.
247. 1 acts downstream of caspase-8 activation by the death-inducing signaling complex, J. Biol. Chem. 273, 3388-3393.
248. Monney, L., Otter, I., Olivier, R., Ravn, U., Mirzasaleh, H., Fellay, I., Poirier, G. G. & Borner, C. (1996) Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain, Biochem. Biophys. Res. Commun. 221, 340-345.
249. Boulakia, C. A., Chen, G., Ng, F. W., Teodoro, J. G., Branton, P. E., Nicholson, D. W., Poirier, G. G. & Shore, G. C. (1996) Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase, Oncogene 12, 529-535.
250. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M. & Kroemer, G. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease, J. Exp. Med. 184, 1331-1341.
251. 1, and Apaf-1 form a ternary complex, J. Biol. Chem. 273, 5841-5845.
252. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. & Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275, 1129-1132.
253. Kluck, R. M., Bossy Wetzel, E., Green, D. R. & Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science 275, 1132-1136.
254. Zhivotovsky, B., Orrenius, S., Brustugun, O. T. & Doskeland, S. O. (1998) Injected cytochrome c induces apoptosis, Nature 391, 449-450.
255. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. L. & Fesik, S. W. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature 381, 335-341.
256. Schendel, S. L., Xie, Z., Montal, M. O., Matsuyama, S., Montal, M. & Reed, J. C. (1997) Channel formation by antiapoptotic protein Bcl-2, Proc. Natl Acad. Sci. USA 94, 5113-5118.
257. 1 forms an ion channel in synthetic lipid membranes, Nature 385, 353-357.
258. 1 regnuates the membrane potential and volume homeostasis of mitochondria, Cell 91, 627-637.
259. Li, F., Srinavassan, A., Wang, Y., Armstrong, R. C. & Tomaselli, K. J. (1997) Cell-specific induction of apoptosis by microinjection of cytochrome c, J Biol. Chem. 272, 30299-30305.
260. Itoh, N., Tsujimoto, Y. & Nagata, S. (1993) Effect of Bcl-2 on Fas antigen-mediated cell death, J. Immunol. 151, 621-627.
261. Mandal, M., Maggirwar, S. B., Sharma, N., Kaufmann, S. H., Sun, S. C. & Kumar, R. (1996) Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-κB signaling pathway, J. Biol. Chem. 271, 30354-30359.
262. Vanhaesebroeck, B., Reed, J. C., De Valck, D., Grooten, J., Miyashita, T., Tanaka, S., Beyaert, R., Van Roy, F. & Fiers, W. (1993) Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor mediated cytotoxicity, Oncogene 8, 1075-1081.
263. Memon, S. A., Moreno, M. B., Petrak, D. & Zacharchuk, C. M. (1995) Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma, J. Immunol. 155, 4644-4652.
264. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K.-M., Krammer, P. H. & Peter, M. E. (1998) Two CD95 (APO-1/Fas) signaling pathways, EMBO J. 17, 1675-1687.
265. Jäättelä, M. (1993) Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor induced activation of phospholipase A2, J. Immunol. 151, 4286-4294.
266. Mehlen, P., Kretz Remy, C., Preville, X. & Arrigo, A. P. (1996) Human hsp27, Drosophila hsp27 and human αB crystallin expression mediated increase in glutathione is essential for the protective activity of these proteins against TNFα induced cell death, EMBO J. 15, 2695-26706.
267. Baichwal, V. R. & Baeuerle, P. A. (1997) Activate NF-κB or die? Curr. Biol. 7, R94-96.
268. Verma, I. M. & Stevenson, J. (1997) IκB kinase: Beginning, not the end, Proc. Natl Acad. Sci. USA 94, 11758-11760.
269. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB, Nature 376, 167-170.
270. Beg, A. A. & Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death, Science 274, 782-784.
271. Wang, C. Y., Mayo, M. W. & Baldwin, A. S. J. (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB, Science 274, 784-787.
272. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB, Science 274, 787-789.
273. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H. & Sonenshein, G. E. (1996) Inhibition of NF-κB/Rel induces apoptosis of murine B cells, EMBO J. 15, 4682-4690.
274. Grilli, M., Pizzi, M., Memo, M. & Spano, P. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation, Science 274, 1383-1385.
275. Grimm, S., Bauer, M. K. A., Baeuerle, P. A. & Schulze-Osthoff, K. (1996) Bcl-2 downregulates the activity of transcription factor NF-κB induced upon apoptosis, J. Cell Biol. 134, 13-23.
276. Lin, K. I., Lee, S. H., Narayanan, R., Baraban, J. M., Hardwick, J. M. & Ratan, R. R. (1995) Thiol agents and Bcl-2 identify an alphavirus induced apoptotic pathway that requires activation of the transcription factor NF-κ B, J. Cell Biol. 131, 1149-1161.
277. Wong, G. H., Elwell, J. H., Oberley, L. W. & Goeddel, D. V. (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor, Cell 58, 923-931.
278. Krikos, A., Laherty, C. D. & Dixit, V. M. (1992) Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements, J. Biol. Chem. 267, 17971-17976.
279. Jäättelä, M., Mouritzen, H., Elling, F. & Bastholm, L. (1996) A20 zinc finger protein inhibits TNF and IL-1 signaling, J. Immunol. 156, 1166-1173.
280. Opipari, A. W. J., Hu, H. M., Yabkowitz, R. & Dixit, V. M. (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity, J. Biol. Chem. 267, 12424-12427.
281. Song, H. Y., Rothe, M. & Goeddel, D. V. (1996) The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation, Proc. Natl. Acad. Sci. USA 93, 6721-6725.